Xefoa Rapid 8 mg FC tablets
PDF Leaflet Revision Date: 01 December 2021
Clinical Summary
Quick overview from the medicine insert
Indication
Short term treatment of mild to moderate pain.
Dosage (summary)
8 mg, not exceeding 16 mg daily; elderly and impaired renal/hepatic function may require reduced frequency.
Onset of Action / Duration
Onset: 30 mins, Duration: 6-8 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation due to risks of renal dysfunction.
Key Drug Interactions
- Anticoagulants
- Sulphonylureas
- Diuretics
- ACE inhibitors
- Lithium
- Methotrexate
Contraindications
- Hypersensitivity to lornoxicam
- Gastrointestinal bleeding
- Severe liver impairment
- Severe renal impairment
- Pregnancy
- Under 18 years
Common side effects
- Nausea
- Dyspepsia
- Abdominal pain
- Diarrhoea
- Vomiting
Counselling Points
- Take before meals with liquid
- Monitor for gastrointestinal symptoms
- Avoid in pregnancy and breastfeeding
Serious warnings
- Risk of gastrointestinal bleeding
- Serious skin reactions
- DRESS syndrome
Important Disclaimer
The Xefoa Rapid 8 mg FC tablets professional information leaflet below is the property of Litha Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
